JP2009515556A - 乳癌リスクを評価する方法 - Google Patents

乳癌リスクを評価する方法 Download PDF

Info

Publication number
JP2009515556A
JP2009515556A JP2008541371A JP2008541371A JP2009515556A JP 2009515556 A JP2009515556 A JP 2009515556A JP 2008541371 A JP2008541371 A JP 2008541371A JP 2008541371 A JP2008541371 A JP 2008541371A JP 2009515556 A JP2009515556 A JP 2009515556A
Authority
JP
Japan
Prior art keywords
breast cancer
adam12
subject
risk
mmp9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008541371A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009515556A5 (https=
Inventor
モーゼス，マーシャ，エー．
ポリーズ，スーザン
ズラコフスキー，デビット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of JP2009515556A publication Critical patent/JP2009515556A/ja
Publication of JP2009515556A5 publication Critical patent/JP2009515556A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2008541371A 2005-11-16 2006-11-16 乳癌リスクを評価する方法 Withdrawn JP2009515556A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73728105P 2005-11-16 2005-11-16
US84645606P 2006-09-22 2006-09-22
PCT/US2006/044684 WO2007059313A1 (en) 2005-11-16 2006-11-16 Method to assess breast cancer risk

Publications (2)

Publication Number Publication Date
JP2009515556A true JP2009515556A (ja) 2009-04-16
JP2009515556A5 JP2009515556A5 (https=) 2011-01-27

Family

ID=37846993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008541371A Withdrawn JP2009515556A (ja) 2005-11-16 2006-11-16 乳癌リスクを評価する方法

Country Status (6)

Country Link
US (1) US20090215102A1 (https=)
EP (1) EP1938105A1 (https=)
JP (1) JP2009515556A (https=)
AU (1) AU2006315348A1 (https=)
CA (1) CA2629793A1 (https=)
WO (1) WO2007059313A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013523186A (ja) * 2010-04-13 2013-06-17 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 多癌侵襲関連機構に基づくバイオマーカー
JP2013528809A (ja) * 2010-06-18 2013-07-11 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング ガン罹患の予測のためのバイオマーカー
JP2020506405A (ja) * 2017-02-08 2020-02-27 シルバイオテック・インコーポレイテッド 乳がんリスクを判定する方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2567079T3 (es) 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
RU2011102743A (ru) * 2008-06-26 2012-08-10 Дана-Фарбер Кэнсер Инститьют, Инк. (Us) Характерные признаки и детерминанты, связанные с метастазированием, и способы их применения
CN101738478A (zh) * 2008-11-27 2010-06-16 浙江大学 Mmp9作为卵巢癌的诊断标记物的用途
AU2010236222B2 (en) * 2009-04-16 2015-10-15 Momenta Pharmaceuticals, Inc. Methods of assessing activity of a polysaccharide composition
BR112012026542A2 (pt) 2010-04-16 2016-07-12 Momenta Pharmaceuticals Inc abordagem seletiva de tecido
CA2795868A1 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
EP2943585B1 (en) * 2013-01-09 2018-07-11 Friedrich-Alexander-Universität Erlangen-Nürnberg Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles
JP2016520613A (ja) 2013-05-28 2016-07-14 モメンタ ファーマシューティカルズ インコーポレイテッド 薬学的組成物
US12320811B2 (en) 2014-05-09 2025-06-03 Ascendant Diagnostics, LLC Methods of detecting cancer
US10613090B2 (en) * 2014-05-09 2020-04-07 Ascendant Diagnostics, LLC Methods of detecting cancer
US20190049455A1 (en) * 2017-08-11 2019-02-14 Panacea Pharmaceuticals Inc. HAAH and MMP-9 are Complementary Cancer Biomarkers and Predictors of Metastasis when Combined
CN114664435A (zh) * 2022-03-28 2022-06-24 上海交通大学医学院附属瑞金医院 先天性肾上腺皮质增生症诊断模型及其构建方法和应用
WO2024086792A2 (en) * 2022-10-21 2024-04-25 The Trustees Of Indiana University Methods for promoting homing and engraftment of hematopoietic stem cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20030264A1 (it) * 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie
AU2005207318B2 (en) * 2004-01-09 2012-02-02 Children's Medical Center Corporation Methods for diagnosis and prognosis of cancers of epithelial origin

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013523186A (ja) * 2010-04-13 2013-06-17 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 多癌侵襲関連機構に基づくバイオマーカー
JP2013528809A (ja) * 2010-06-18 2013-07-11 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング ガン罹患の予測のためのバイオマーカー
JP2020506405A (ja) * 2017-02-08 2020-02-27 シルバイオテック・インコーポレイテッド 乳がんリスクを判定する方法

Also Published As

Publication number Publication date
EP1938105A1 (en) 2008-07-02
US20090215102A1 (en) 2009-08-27
WO2007059313A1 (en) 2007-05-24
AU2006315348A1 (en) 2007-05-24
CA2629793A1 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
US20190361028A1 (en) Free ngal as a biomarker for cancer
JP5006802B2 (ja) 上皮由来の癌診断および予後診断のためのバイオマーカーとしてのＣｙｒ６１
US8685659B2 (en) Method for diagnosis and prognosis of epithelial cancers
JP2009515556A (ja) 乳癌リスクを評価する方法
US20100209944A1 (en) Adamts-7 as a biomarker for cancers of epithelial origin
US20180156808A1 (en) Methods for diagnosis and prognosis of cancers of epithelial origin
US20120022793A1 (en) Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population
US20260104417A1 (en) Use of urinary protein biomarkers to distinguish between neoplastic and non-neoplastic disease of the prostate
CN101346629A (zh) 评估乳癌风险的方法
US20210181200A1 (en) Ovarian cancer biomarker and methods of using same
CA2747184A1 (en) Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091113

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091113

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20110405

A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20110405